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STEVENS, S., S. KNOLLEMA, G. I. DE JONG, J. KORF, AND P. G. M. LUITEN. Long-term food restriction, deprenyl, and
nimodipine treatment on life expectancy and blood pressure of stroke prone rats. NEUROBIOL AGING 19(3) 273–276, 1998.—We
determined whether food restriction or the drugs nimodipine (Ca21 antagonist) and deprenyl (a MAO-B inhibitor) prevent the
development of stroke in the spontaneously hypertensive stroke-prone rat (SHR-SP). Forty male SHR-SP rats, in the age of 34 weeks,
were exposed to various treatments. During a period of 27 weeks, survival and blood pressure were followed. In the control and
deprenyl group, the blood pressure values remained unchanged; 50% had died after 27 weeks. All rats that were treated with nimodipine
survived. After food restriction, 7/8 rats survived and showed a lower blood pressure. This study in SHR-PR rats shows the superiority
of nimodipine on survival, and the potential of food restriction as a stroke-preventing measure. © 1998 Elsevier Science Inc.
Stroke prevention Deprenyl Nimodipine Food restriction Stroke-prone rats Hypertension Blood
pressure
ESSENTIAL hypertension is a major risk factor for stroke (21).
The spontaneously hypertensive stroke-prone (SHR-SP) rat strain
(20) may serve as a model of hypertension and stroke. At
approximately the age of 43–52 weeks, SHR-SP rats develop
cerebral hemorrhages and infarcts located in the boundaries of the
flow region of the middle cerebral artery. As a consequence, the
lifespan of SHR-SP rats is considerably shortened, which makes
SHR-SP rats particularly suitable to assess prophylactic interven-
tions. Of the cytotoxic events leading to neuronal death following
cerebral ischemia, excessive calcium influx, acidosis, and free
radicals are crucial (3,8,9,12,17,22–24,). Previously, it was dem-
onstrated that long-term treatment with the calcium antagonist
nimodipine prevented neocortical strokes in SHR-SP rats up to 56
weeks (12,13). The beneficial effects of treatment with free radical
scavengers in acute or global cerebral ischemia models are
suggested in several studies (1,8). Free radicals are formed by
monamine oxidase type B (MAO-B), which may explain not only
the neuroprotection in stroke models (e.g., 8), but also the
longevity of (normotensive) rodents after long-term treatment with
deprenyl (2,6,11). Another way to protect against stroke is by
starvation, which possibly is caused by a diminished hyperglycae-
mic response after hypoxia (3,15). Interestingly, normotensive
rodents extend the lifespan following food restriction.
Here, we describe the efficacy of long-term food restriction and
treatment with deprenyl or nimodipine on blood pressure and
survival of adult SHR-RP rats.
MATERIALS AND METHODS
Animals and Treatment
Forty male SHR-SP (breeder Møllegaard Scønevød, Denmark)
were housed in groups of 6 or 4 animals. At the age of 34 weeks
animals were divided into 5 groups and individually housed.
Accordingly, the 1) Onset-control group (n 5 4); 2) Control group
(n 5 12) and 3) Deprenyl group (n 5 10) had free access to water
and standard lab chow. An oral daily dose L-deprenyl 5 mg/kg was
added to the drinking water and adjusted weekly to maintain the
dose within 90–111% (1,2). The Food restriction group (n 5 8)
received 60% of the normal food intake with Vitamin supplements.
The volume of this food was normalized to the volume of food in
the control group with ingestible cellulose. To the Nimodipine
group (n 5 6) water and food were supplied ad libitum, while the
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latter contained 860 ppm nimodipine (Bayer AG, Leverkusen,
Germany). The drug treatments and food deprivation regimen were
carried out for 27 weeks (from 34–61 weeks) and the body weight
was recorded weekly. At ages of 32, 36, 37, 40, 44, 48, 52, 57, and
61 weeks systolic blood pressure (SBP) was measured. The SBP
measurement was carried out under light ether anesthesia with the
tail-cuff method using a photoelectric sensor unit to detect arterial
pulse visualized on an oscilloscope. The pressure in the cuff placed
around the base of the tail was gradually elevated until the
pulsation disappeared. During gradual decreasing of the pressure
the SBP was read on a manometer at the moment of the
reappearance of pulses, expressed in mmHg.
The animals were checked daily on hyperirritability, hemiple-
gia, apathy, and motor disturbance. Brain weight (excluding
olfactory bulb and lower medulla) and appearance of stroke and
brain edema was assessed in the Onset-control group after 34
weeks, and at the age 61 weeks for the surviving animals. Cell
damage in the surviving animals was visualized with silverstaining
(25). Blood glucose levels were measured at 32 weeks and 14 days
after the start of the treatments. Blood samples for glucose
FIG. 1. Changes in bodyweight, survival, and blood pressure during various treatment regimens of adult SHR-SP rats. Rats were either given
nimodipine, deprenyl, or a low amount of food. Results are given as mean 6 SEM, during the treatment period. In A, * indicates time point
from where the weight in the food restriction group differs significantly (p , 0.05) from controls or any other group. In panel B the survival
rate following various treatments differed significantly from control animals at * (p , 0.05). In C and D the blood pressure after food
restriction increased transiently and decreased significanty thereafter (* p , 0.05) as compared to control or other treatment groups. -M-:
controls; -E-: deprenyl; --: food restriction; --: nimodipine. Number of observations per Group 6–10 rats.
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measurements were obtained in the first half of the light period.
Blood samples were immediately transferred to a chilled (0°C)
medium containing EDTA and 10 mL heparin (500 U/mL). Blood
glucose (50 mL blood) was measured by the ferricyanide method
of Hoffman (Technicon Auto Analyzer TMII). The protocol was
approved by the committee supervising animal experimentation of
the Faculty of Medical Science (University of Groningen).
Data Analysis
Investigators were blind to the procedures during blood pres-
sure measurements, weighing, glucose analysis, and histology.
Data shown are presented as mean 6 SEM. Blood pressure value
and weight each different time points were statistically evaluated
using one-way analysis of variance (ANOVA), which in case of
significant group differences, was followed by a post hoc Bonfer-
roni test. To establish the effect of the different treatment strategies
in time and the interaction of time and treatment on blood pressure
we used a RM-ANOVA evaluated by a F-test. In this test time and
treatment are a factor with a first-order interaction between time
and treatment. Survival data were statistically evaluated using
Kaplan-Meier survival analysis, and to test the equality of the
survival distributions for the different groups we used the Log-
Rank test. Differences were defined as significant when p , 0.05.
RESULTS
General Condition
The bodyweight of the SHR-SP rats during treatment with
nimodipine and deprenyl was not significantly different from that
of controls, whereas the bodyweight of food restricted rats was
from Week 36 onwards significantly lower (until 81% of the
bodyweight at 32 weeks; Fig. 1A). The blood glucose levels (in
mM/L 6 SEM, 4–10 observations) as measured in all 4 groups at
the age of 32 weeks and 14 days after onset of the treatment were
7.85 6 0.40 (control), vs. 7.71 6 0.57 (food restriction), 7.93 6
0.51 (deprenyl), and 7.63 6 0.67 (nimodipine). No significant
differences were found between the groups. Of the surviving rats
at the age of 61 weeks the brains did not reveal signs of infarction
or edema (data not shown).
Survival
None of the nimodipine-treated animals died and their survival
rate was significantly increased (p , 0.05). Of the control,
deprenyl-treated, and food-restricted rats, 50%, 50%, and 12.5%,
respectively, died. All the animals that had died before the end of
the experiment displayed neurological symptoms of stroke and
most likely died as a consequence of stroke. Figure 1B shows the
survival rate in the different groups during the experiment.
Blood Pressure
Figures 1C and D show the time course of blood pressure.
Food-restricted rats showed at the age of 36 weeks a temporary but
significant (p , 0.05) rise in blood pressure (266.0 mmHg 6 18.0
vs. 167.2 mmHg 6 18.7, in controls) (Fig. 1c) and a significantly
(p , 0.001) lowering effect thereafter. Long-term treatment with
deprenyl or nimodipine did not affect blood pressure (Fig. 1D).
DISCUSSION
We confirmed and extended the observation (12) that nimodip-
ine treatment prevents stroke and enhances survival of SHR-SP
rats. New are the data that long-term deprenyl treatment does not
prevent stroke nor influence the survival rate, and that food
restriction may offer neuroprotection in SHR-SR rats. MAO
inhibitors are known to give a rise in blood pressure, but deprenyl
is an exception (5). The present data are in line with the clinical
observation (6). A dose of 5 mg/kg p.o. was used, which
corresponds to the ED50 for the selective cerebral MAO-B inhib-
itor after oral administration in the rat (1). Apart from the
neuroprotective effect in cerebral ischemia, deprenyl treatment is
also claimed to increase the life-expectancy in rodents and patients
suffering from Parkinson disease (6,7). However, conflicting data
are published concerning the safety of long-term deprenyl use
(e.g., when combined with Levodopa; (10)).
Food restriction is generally known to increase life expectancy
and to retard the occurrence of age-associated processes such as
nephropathy, cardiomyopathy, and neoplasia (14,16,28). The
present study shows the prophylactic effect of food restriction on
the development of hypertension when food restriction is started at
adult age. To our knowledge, the present study is the first to
describe the effect of food restriction on lifespan and blood
pressure in SHR-SP rats when given at adult age. Other studies
showed a decrease in blood pressure or/and an increase in lifespan
after food restriction in hypertensive animals if food restriction
was performed for a short period (4 days) or for a longer period up
to 8 weeks only in young animals (4,5,18,19,26,27). The lowering
effect of food restriction on blood pressure did not result in a
significant increase in survival in our study, although this may be
largely due to the small sample size. The initial rise in systolic
blood pressure in the first 2 weeks in this study may be the result
of a stress effect of food deprivation. Stroke in the SHR-SP rats is
hypothesized to be the result of an enhanced vulnerability of the
vasculature for pressure load caused by an altered vascular
metabolism and physical damage to the vessel wall from the high
blood pressure (20). To what extent the changes in metabolism
may play a role in the increased survival is not clear from the
present study, because blood glucose levels are measured only at
one time. However, our results indicate that changes in blood
pressure may be independent of the blood glucose levels, because
these levels do not change after the start of food restriction.
In conclusion, this preliminary study shows that nimodipine
prevented stroke most effectively, that food restriction had a
profound beneficial impact on hypertension by decreasing blood
pressure in SHR-SP rats, and that the results with deprenyl were
negative. Both the effective treatments either given apart or in
combination may provide neuroprotection in stroke-prone individ-
uals even when started in the adult.
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